NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: HeartBeam Inc.'s Global Recognition in 12-Lead ECG Innovation
TL;DR
HeartBeam's second-place global ranking in 12-lead ECG innovation positions it as a strong competitor to GE Healthcare in the portable cardiac diagnostics market.
HeartBeam's proprietary synthesis-ECG system captures heart signals in three dimensions and synthesizes them into a 12-lead ECG using compact, portable devices.
HeartBeam's technology enables high-quality cardiac monitoring outside hospitals, improving arrhythmia assessment accessibility and potentially saving lives in remote locations.
HeartBeam holds 13 U.S. patents for its cable-free 3D ECG technology that creates cardiologist-level data from portable devices anywhere.
Found this article helpful?
Share it with your network and spread the knowledge!
The article reports that HeartBeam Inc. has been recognized as a Global IP and Technology Leader in Portable Cardiac Diagnostics, ranking second worldwide in 12-lead ECG innovation among 243 firms analyzed, according to PatentVest's "Total Cardiac Intelligence" report.
This ranking highlights HeartBeam's growing influence in the next generation of cardiac monitoring technology and underscores the rapid maturation of the company's proprietary synthesis-ECG system, which addresses the challenge of delivering high-quality cardiac monitoring for arrhythmia assessment wherever patients are.
HeartBeam's proprietary synthesis-ECG system captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG, allowing physicians to obtain cardiologist-level ECG data from compact devices that can be used by patients or clinicians far from traditional hospital settings.
The company's technology is currently cleared for arrhythmia assessment, with ischemia being a future goal for the platform.
HeartBeam ranked second worldwide in 12-lead ECG innovation among 243 firms analyzed, trailing only GE Healthcare, which demonstrates its strong position in the global market for portable cardiac diagnostics technology.
HeartBeam is creating the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions, designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence outside of medical facilities.
The company holds 13 U.S. and 4 international-issued patents related to technology enablement for its cardiac monitoring platform.
For more information, visit www.HeartBeam.com or the company's newsroom at https://ibn.fm/BEAT for the latest news and updates relating to BEAT.
Physicians can identify cardiac health trends and acute conditions and direct patients to appropriate care outside of medical facilities, while patients can receive high-quality cardiac monitoring wherever they are, redefining the future of cardiac health management.
The article was published by AINewsWire, which is part of the Dynamic Brand Portfolio at IBN, and the full article can be viewed at https://ibn.fm/3ADRP.
Curated from InvestorBrandNetwork (IBN)
